BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 6683136)

  • 1. Direct hyperbilirubinemia complicating ABO hemolytic disease of the newborn.
    Sivan Y; Merlob P; Nutman J; Reisner SH
    Clin Pediatr (Phila); 1983 Aug; 22(8):537-8. PubMed ID: 6683136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABO hemolytic disease of the newborn associated with direct reacting hyperbilirubinemia.
    Najak Z; Kanto WP; Carrillo PJ
    J Med Assoc Ga; 1982 Apr; 71(4):267-71. PubMed ID: 7200505
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of Gilbert's Syndrome-Associated UGT1A1 Polymorphism in Jaundiced Neonates of ABO Incompatibility Hemolysis Disease.
    Yu Y; Du L; Chen A; Chen L
    Am J Perinatol; 2020 May; 37(6):652-658. PubMed ID: 31087315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABO hemolytic disease of the newborn. A retrospective analysis of 254 cases.
    Dufour DR; Monoghan WP
    Am J Clin Pathol; 1980 Mar; 73(3):369-73. PubMed ID: 7189092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early diagnosis of ABO haemolytic disease of the newborn.
    Procianoy RS; Giacomini CB; Farina DM; Mollin GA; Winckler MI; Silveira MB; Campos L; Marques-Pereira JP
    Eur J Pediatr; 1987 Jul; 146(4):390-3. PubMed ID: 3653135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [FamiliaL hemolytic disease in the newborn infant with direct hyperbilirubinemia].
    Sivan Y; Mimouni M; Merlob P
    Ann Pediatr (Paris); 1986 Apr; 33(4):359-61. PubMed ID: 3729248
    [No Abstract]   [Full Text] [Related]  

  • 7. [Practical and clinical problems in hemolytic disease of the newborn].
    Kaloud H
    Wien Med Wochenschr; 1966 Nov; 116(46):975-80. PubMed ID: 4965842
    [No Abstract]   [Full Text] [Related]  

  • 8. Familial occurrence of hemolytic disease of the newborn due to AO blood group incompatibility.
    Plotz RD
    Hum Pathol; 1985 Feb; 16(2):113-6. PubMed ID: 3972392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for readmission for hyperbilirubinemia in neonates with ABO hemolytic disease: a single-center retrospective cohort study.
    Xu C; Bao Y; He Y; Wu M; Zhu J
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2238106. PubMed ID: 37487760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugated hyperbilirubinemia in infants with erythroblastosis fetalis.
    Hegyi T; Polin RA; Driscoll JM
    Am J Gastroenterol; 1979 Sep; 72(3):297-301. PubMed ID: 507034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of ABO haemolytic disease of the newborn in a group of Hong Kong babies with severe neonatal jaundice.
    Feng CS; Wan CP; Lau J; Lam TK; Fok TF
    J Paediatr Child Health; 1990 Jun; 26(3):155-7. PubMed ID: 2206617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal intrahepatic cholestasis secondary to BO hemolytic disease.
    Raju TN; Javed DI
    J Natl Med Assoc; 1981 Aug; 73(8):747-9. PubMed ID: 7196459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The benefit of the direct antiglobulin test using gel technique in ABO hemolytic disease of the newborn.
    Chuansumrit A; Siripoonya P; Nathalang O; Sriphaisal T
    Southeast Asian J Trop Med Public Health; 1997 Jun; 28(2):428-31. PubMed ID: 9444034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Incidence, laboratory diagnosis and serologic prediction of hemolytic disease of newborn infants due to ABO incompatibility].
    Schönitzer D; Frisch H
    Padiatr Padol; 1984; 19(3):263-78. PubMed ID: 6472867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxyhemoglobin measurements in the diagnosis of ABO hemolytic disease.
    Uetani Y; Nakamura H; Okamoto O; Yamazaki T; Vreman HJ; Stevenson DK
    Acta Paediatr Jpn; 1989 Apr; 31(2):171-6. PubMed ID: 2516696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence rate of ABO hemolytic disease of the newborn.
    Katz MA; Kanto WP; Korotkin JH
    Obstet Gynecol; 1982 May; 59(5):611-4. PubMed ID: 7070734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of early interventions for ABO hemolytic disease of the newborn].
    Huang WM; Chen HW; Li N; Yang M; Jiao PY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1350-1, 1355. PubMed ID: 16982453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABO hemolytic disease of the newborn: evaluation of management and identification of racial and antigenic factors.
    Peevy KJ; Wiseman HJ
    Pediatrics; 1978 Mar; 61(3):475-8. PubMed ID: 565506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal BO Incompatibility Is Associated With a Positive Cord Blood Direct Antiglobulin Test in Infants of Black Ethnicity.
    Özgönenel B; Kukreja G; O'Malley B; Bluth MH
    J Pediatr Hematol Oncol; 2015 Nov; 37(8):e453-7. PubMed ID: 26422285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.